Showing 1 - 10 of 32
Persistent link: https://www.econbiz.de/10003480971
Persistent link: https://www.econbiz.de/10008349565
In 2009, Sanofi-Aventis, whose generic subsidiary is Winthrop, merges with the generic firm, Zentiva. This paper fills the gap in the theoretical literature concerning mergers in pharmaceutical markets. To prevent generic firms from increasing their market share, some brand-name firms produce...
Persistent link: https://www.econbiz.de/10014187773
Persistent link: https://www.econbiz.de/10003743429
Persistent link: https://www.econbiz.de/10003923285
Persistent link: https://www.econbiz.de/10009572774
Persistent link: https://www.econbiz.de/10008935455
For several years, European financial markets have been the place of important mutations. These mutations have hit both stock markets themselves as well as the infrastructures including all necessary services for the transactions on financial securities. Among the market services to which the...
Persistent link: https://www.econbiz.de/10013036958
Persistent Organic Pollutants (POPs) threaten human health and the global environment. Recognizing their dangers many countries began to limit or ban POPs production, use, and release in the 1990s. Eventually the Stockholm Convention on POPs, was adopted in 2001 and entered into force in 2004....
Persistent link: https://www.econbiz.de/10010994807
This paper fills the gap in the theoretical literature concerning mergers between brand-name and generic laboratories in pharmaceutical markets. To prevent generic firms from increasing their market share, some brand-name firms produce generics themselves, called pseudo-generics. We show, in a...
Persistent link: https://www.econbiz.de/10011020444